Linking Amyloid-β and Tau: Amyloid-β Induced Synaptic Dysfunction via Local Wreckage of the Neuronal Cytoskeleton
- 7 December 2011
- journal article
- Published by S. Karger AG in Neurodegenerative Diseases
- Vol. 10 (1-4), 64-72
- https://doi.org/10.1159/000332816
Abstract
Background: In Alzheimer's disease (AD), amyloid-beta (A beta) is the major component of extracellular plaques, whereas the microtubule-associated protein tau forms the main component of intracellular tangles. In contrast to frontotemporal dementias and other neurodegenerative diseases, both proteins form pathological aggregates and are considered key players for the development of AD. However, the connection between A beta and tau and the functional loss of neurons and synapses, which ultimately lead to cognitive impairments, is still not well understood. Objectives: Making use of primary neurons exposed to A beta oligomers, we sought to determine how tau mediates the A beta-induced neuronal dysfunction. Additionally, we asked how the microtubule cytoskeleton is involved in the combined A beta and tau toxicity. Methods: We exposed mature primary rat neurons with developed synapses to A beta oligomers and used immunofluorescence and electron microscopy to investigate tau, actin, neurofilament and microtuble cytoskeleton changes. Results: A beta oligomers preferentially associate with synapses, notably dendritic spines, throughout the neuronal cell culture. As a consequence, endogenous tau gets missorted from the axonal into the somatodendritic compartment in a subset of cells. These missorted cells also display missorting of neurofilaments, and a dramatic loss of microtubules, which can be prevented by the microtubule stabilizer taxol. Conclusions: A beta causes tau missorting, loss of neuronal cell polarity and loss of dendritic microtubules. This in turn leads to impaired organelle/mitochondria transport, whereby synapses cannot be maintained properly and eventually decay. The data support the view that the microtubule cytoskeleton is a valid therapeutic target in AD. Copyright (C) 2011 S. Karger AG, BaseKeywords
This publication has 21 references indexed in Scilit:
- Amyloid-Dependent and Amyloid-Independent Stages of Alzheimer DiseaseArchives of Neurology, 2011
- Amyloid-β/Fyn–Induced Synaptic, Network, and Cognitive Impairments Depend on Tau Levels in Multiple Mouse Models of Alzheimer's DiseaseJournal of Neuroscience, 2011
- Dendritic Function of Tau Mediates Amyloid-β Toxicity in Alzheimer's Disease Mouse ModelsCell, 2010
- The secretases: enzymes with therapeutic potential in Alzheimer diseaseNature Reviews Neurology, 2010
- Alzheimer's disease: synaptic dysfunction and AβMolecular Neurodegeneration, 2009
- Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptideNature Reviews Molecular Cell Biology, 2007
- Aβ Oligomers – a decade of discoveryJournal of Neurochemistry, 2007
- Alzheimer’s disease: intraneuronal alterations precede insoluble amyloid-β formationNeurobiology of Aging, 2004
- Small assemblies of unmodified amyloid β-protein are the proximate neurotoxin in Alzheimer’s diseaseNeurobiology of Aging, 2004
- Synaptic slaughter in Alzheimer's diseaseNeurobiology of Aging, 2003